Please assess the completion status of the following clinical trial:

Trial Title: Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Age \>/= 18~2. At least one peripheral lung lesion \>8mm documented on CT scan referred for diagnostic bronchoscopy~3. Subject is able to undergo informed consent~Exclusion Criteria:~1. Coagulopathy (platelet count \< 50,000, INR \> 1.5) detected on blood testing done within 6 weeks of the procedural visit~2. Lesion associated with a prominent vessel evident on CT scan~3. Pure ground glass lesion~4. Fibrotic interstitial lung abnormalities on chest CT~5. Bullous emphysema in region of nodule~6. Supplemental oxygen utilization at baseline~7. BMI \> 40~8. End stage renal disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Single intervention arm - transbronchial biopsy (Type: EXPERIMENTAL): Patients enrolled in this single arm study will have lung nodules biopsied by traditional forceps followed by transbronchial cryobiopsy

Based on this trial design, predict the completion outcome and termination type (if applicable).